Catalyst Wire Dossier Catalyst Wire Dossier

Pluvicto

lutetium-177 PSMA-617 · Novartis
Drug timelines are a Plus or Pro feature.

41 regulatory and trial events tracked for Pluvicto, covering 2022-03-23 to 2026-07-31. Get the full timeline:

Most recent: FDA Approved: PLUVICTO — Supplemental Application (Novartis Pharmaceuticals Corporation)

See pricing